2-Deoxyglucose induces β-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex

Acta Neurobiologiae Experimentalis

Volumn 64, Issue 4, 2004, Pages 491-502

  Grieb, Pawel ^a   Gordon Krajcer, Wanda ^a   Frontczak Baniewicz, Małgorzata ^a   Walski, Michał ^a   Ryba, Miroslaw S ^a   Kryczka, Tomasz ^a   Fiedorowicz, Michal ^a   Kulinowski, Piotr ^b   Sułek, Zenon ^b   Majcher, Katarzyna ^b   Jasiński, Andrzej ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b INSTITUTE OF NUCLEAR PHYSICS   (Poland)

Author keywords

2 deoxyglucose; Beta amyloid precursor protein; Brain cortex; Golgi apparatus; Phosphorous magnetic resonance spectroscopy; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DEOXYGLUCOSE; GLUCOSE 6 PHOSPHATE ISOMERASE; INSULIN RECEPTOR; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN CORTEX; BRAIN TISSUE; CELL DEATH; CELL ULTRASTRUCTURE; COMPLEX FORMATION; EVOKED RESPONSE; GENE OVEREXPRESSION; GOLGI COMPLEX; INSULIN RESISTANCE; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STRESS;

AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES; CELL COUNT; CEREBRAL CORTEX; DEOXYGLUCOSE; GOLGI APPARATUS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; PHOSPHORYLATION; RATS; RATS, WISTAR; TAU PROTEINS; TIME FACTORS;

EID: 9644277048     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Agardh CD, Kalimo H, Olsson Y, Siesjo BK (1981) Hypoglycemic brain injury: metabolic and structural findings in rat cerebellar cortex during profound insulin-induced hypoglycemia and in the recovery period following glucose administration. J Cereb Blood Flow Metab 1: 71-84.
2. Alpin AE, Gibb GM, Jacobsen JS, Gallo J-M, Anderton BH (1996) In vitro phosphorylation of cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3β. J Neurochem 67: 699-707.
3. Aplin AE, Jacobsen JS, Anderton BH, Gallo JM (1997) Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells. Neuroreport 8: 639-643.
4. 31P nuclear magnetic spectroscopy. Science 228: 1329-1331.
5. Dreau D, Foster M, Morton DS, Fowler N, Kinney K, Sonnenfeld G (2000) Immune alterations in three mouse strains following 2-deoxy-D-glucose administration. Physiol Behav 70: 513-520.
6. Elyaman W, Yardin C, Hugon J (2002) Involvement of glycogen synthase kinase-3β and tau phosphorylation in neuronal Golgi disassembly. J Neurochem 81: 870-880.
7. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 35: 1-6.
8. Gabuzda D, Busciglio J, Chen L, Matsudaira P, Yankner B (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem. 269: 13623-13628.
9. 2+/ calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A 85: 6218-6221.
10. Grieb P, Kryczka T, Fiedorowicz M, Frontczak-Baniewicz M, Walski M (2004) Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. Acta Neurobiol Exp (Wars) 64: 481-489.
11. Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signalling. Prog Neurobiol 65: 391-426.
12. Hardy J, Higgins GA (1992) Alzheimer's disease: The amyloid hypothesis. Science 256: 1124-1125.
13. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
14. Horton RW, Meldrum BS, Bachelard HS (1973) Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem 21: 507-520.
15. Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus. A challenging hypothesis. J Neural Transm 105: 415-422.
16. Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109: 341-360.
17. Johnson G, Refolo LM, Merril CR, Wallace W (1993) Altered expression and phosphorylation of amyloid precursor protein in heat shocked neuronal PC12 cells. Brain Res Mol Brain Res 19: 140-148.
18. Kadowaki T, Kasaga M, Akamuma Y, Ezaki O, Takaku F (1984) Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin diabetic rats. J Biol Chem 259: 14208-14216.
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
20. Lee CW, Lau KF, Miller CC, Shaw PC (2003) Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport 14: 257-560.
21. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, Mattson MP (1999) 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J Neurosci Res 57: 48-61.
22. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4: 1077-1086.
23. Mattson MP (1997) Cellular actions of β-Amyloid Precursor Protein and its soluble and fibrillogenic derivatives. Physiol Rev 77: 1081-1132.
24. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42: 85-94.
25. Ogawa M, Fukuyama H, Ouchi Y, Yamauchi H, Kimura J (1996) Altered energy metabolism in Alzheimer's disease. J Neurol Sci 139: 78-82.
26. Pascoe WS, Smythe GA, Storlie LH (1989) 2-Deoxy-D-glucose-induced hyperglycemia: role for direct sympathetic nervous system activation of liver glucose output. Brain Res 505: 23-28.
27. Pedersen WA, Culmsee C, Ziegler D, Herman JP, Mattson MP (1999) Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci 13: 159-165.
28. Perez RG, Zheng H, Van der Ploeg LH, Koo EH (1997) The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J Neurosci 17: 9407-9414.
29. Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE (1996) Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med 37: 201-208.
30. Rejdak K, Rejdak R, Sieklucka-Dziuba M, Stelmasiak Z, Grieb P (2001) 2-Deoxyglucose enhances hypoxic tolerance evoked by transient incomplete brain ischemia. Epilepsy Res 43: 271-278.
31. Ryba MS, Gordon-Krajcer W, Walski M, Chalimoniuk M, Chrapusta SJ (1999) Hydroxylamine attenuates the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome. Brain Res 850: 225-233.
32. Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulphate polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Anal Biochem 166: 638-661.
33. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766.
34. Shi J, Xiang Y, Simpkins JW (1997) Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells. Brain Res 772: 247-251.
35. Simon RP, Schmidley JW, Swan JH, Meldrum BS (1986) Neuronal alterations in hippocampus following severe hypoglycaemia: a light microscopic and ultrastructural study in the rat. Neuropathol Appl Neurobiol 12: 11-26.
36. Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, Mattson MP (1994) Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem 63: 781-784.
37. Swaab DF, Dubelaar EJ, Hofman MA, Scherder EJ, van Someren EJ, Verwer RW (2002) Brain aging and Alzheimer's disease: use it or lose it. Prog Brain Res 138: 343-373.
38. Tomimoto H, Wakita H, Akiguchi I, Nakamura S, Kimura J (1994) Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress. J Cereb Blood Flow Metab 14: 565-573.
39. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.
40. Wallace W, Johnson G, Sugar J, Merril CR, Refolo LM (1993) Reversible phosphorylation of tau to form A68 in heat-shocked neuronal PC12 cells. Brain Res Mol Brain Res 19: 149-155.
41. Wan R, Camandola S, Mattson MP (2003) Intermittent fasting and dietary supplementation with 2-deoxy-D-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB J 17: 1133-1134.
42. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyeruther K (1989) Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57: 115-126.
43. Wick AN, Drury DR, Nakada HI, Wolfe JB (1957) Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 224: 963-969.
44. Wierzba-Bobrowicz T (1980) Electron-microscopic picture of rat brain in acute experimental hypoglycemia (in Polish). Neuropatol Pol 18: 289-300.
45. Xie L., Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R (2002) Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22: RC221.
46. Yanagisawa M, Planel E, Ishiguro K, Fujita SC (1999) Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett 461: 329-333.
47. Yu ZF, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 57: 830-839.